One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsDietger Niederwieser, Wael Saber, Sebastián Galeano et al.|Haematologica|2021Cited by 236
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationKai Hübel, Rafael F. Duarte, M M Fresen et al.|Bone Marrow Transplantation|2011Cited by 65
Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or LenalidomideFlorent Malard, Rafael F. Duarte, Nicolaus Kröger et al.|Biology of Blood and Marrow Transplantation|2011Cited by 44